Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cook Medical has enrolled the first US patient in the Stable global clinical trial, designed to evaluate the Cook Zenith Dissection Endovascular System for the treatment of type B thoracic aortic dissections.
Subscribe to our email newsletter
The patient was treated with the Cook Zenith Dissection Endovascular System, which is comprised of the new Cook Zenith Dissection Stent, used in conjunction with the Cook Zenith TX2 Endovascular Graft. The Cook Zenith Dissection Endovascular System is intended for use in the endovascular treatment of descending thoracic aortic dissection in patients with anatomies appropriate for endovascular repair.
Phil Nowell, global director of Aortic Intervention strategic business unit, at Cook, said: “We anticipate that the Stable trial will confirm the success of the Cook Zenith Dissection Endovascular System and highlight the positive outcomes for our patients.”